This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Németh, K. et al. Nat. Med. 15, 42–49 (2009).
Tyndall, A. & Pistoia, V. Nat. Med. 15, 18–20 (2009).
Dyson, A. & Singer, M. Crit. Care Med. 37, S30–S37 (2009).
Hotchkiss, R.S. & Karl, E.I. N. Engl. J. Med. 348, 138–150 (2003).
Monneret, G., Venet, F., Pachot, A. & Lepape, A. Mol. Med. 14, 64–78 (2008).
Munford, R.S. & Pugin, J. Am. J. Respir. Crit. Care Med. 163, 316–321 (2001).
Venet, F. et al. Intensive Care Med. 35, 678–686 (2009).
Pugin, J. Novartis Found. Symp. 280, 21–27 (2007).
Rittirsch, D. et al. Nat. Protoc. 4, 31–36 (2009).
Wang, H. et al. Science 285, 248–251 (1999).
Flierl, M.A. et al. FASEB J. 22, 2198–2205 (2008).
Lenfant, C. N. Engl. J. Med. 349, 868–874 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Monneret, G. Mesenchymal stem cells: another anti-inflammatory treatment for sepsis?. Nat Med 15, 601–602 (2009). https://doi.org/10.1038/nm0609-601
Issue Date:
DOI: https://doi.org/10.1038/nm0609-601